| scholarly article | Q13442814 |
| P50 | author | Song Wang | Q118432586 |
| Xiaojuan Chi | Q118432648 | ||
| Ji-Long Chen | Q40092542 | ||
| P2093 | author name string | Jing Zhang | |
| Chao Chen | |||
| Zhou Yang | |||
| P2860 | cites work | Pandemic Threat Posed by Avian Influenza A Viruses | Q22299330 |
| Vaccines and antiviral drugs in pandemic preparedness | Q22305646 | ||
| The structure and receptor binding properties of the 1918 influenza hemagglutinin | Q27643092 | ||
| Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus | Q27643093 | ||
| Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin | Q27677191 | ||
| Mechanisms of gene silencing by double-stranded RNA | Q28282560 | ||
| Equine influenza: A review of an unpredictable virus | Q37777772 | ||
| An overview of influenza A virus receptors | Q37857873 | ||
| T cell mediated immunity to influenza: mechanisms of viral control | Q38231916 | ||
| In vitro validation of self designed "universal human Influenza A siRNA". | Q38837014 | ||
| NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription | Q38926956 | ||
| eIF4B phosphorylation by pim kinases plays a critical role in cellular transformation by Abl oncogenes | Q39142024 | ||
| Suppression of avian influenza transmission in genetically modified chickens. | Q39608141 | ||
| Transgenic mouse model integrating siRNA targeting the foot and mouth disease virus | Q39736605 | ||
| The use of RNAi and transgenics to develop viral disease resistant livestock | Q39935831 | ||
| Variation of influenza A, B, and C viruses | Q40326626 | ||
| Synergic and antagonistic effect of small hairpin RNAs targeting the NS gene of the influenza A virus in cells and mice. | Q41752306 | ||
| Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. | Q41983597 | ||
| Oseltamivir resistance during treatment of H7N9 infection | Q42287342 | ||
| Role of Itk signalling in the interaction between influenza A virus and T-cells | Q45359929 | ||
| Viral infection resistance conferred on mice by siRNA transgenesis | Q48383529 | ||
| Molecular mechanisms of RNA interference | Q28290306 | ||
| Influenza: old and new threats | Q28296381 | ||
| Strategies for mitigating an influenza pandemic | Q29615422 | ||
| Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus | Q29622936 | ||
| Development of effective vaccines against pandemic influenza. | Q30352566 | ||
| Cell-mediated protection in influenza infection. | Q30353071 | ||
| Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus. | Q30353786 | ||
| Antiviral agents active against influenza A viruses. | Q30358429 | ||
| Medical management of influenza infection. | Q30365221 | ||
| Antivirals and the control of influenza outbreaks. | Q30365466 | ||
| Reassortment patterns in Swine influenza viruses. | Q30381424 | ||
| Drugs in development for influenza | Q30391218 | ||
| Influenza virus resistance to neuraminidase inhibitors. | Q30428660 | ||
| Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A ferret model | Q30430458 | ||
| Molecular basis for the generation in pigs of influenza A viruses with pandemic potential | Q30431215 | ||
| Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication. | Q33455759 | ||
| Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo | Q33712990 | ||
| In vivo RNAi: today and tomorrow | Q34014698 | ||
| Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression. | Q34057790 | ||
| Permissive secondary mutations enable the evolution of influenza oseltamivir resistance | Q34118992 | ||
| Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins | Q34253111 | ||
| Inhibition of influenza virus production in virus-infected mice by RNA interference | Q34514513 | ||
| Protection against lethal influenza virus challenge by RNA interference in vivo. | Q34514565 | ||
| Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways | Q34530552 | ||
| DNA constructs designed to produce short hairpin, interfering RNAs in transgenic mice sometimes show early lethality and an interferon response. | Q34557389 | ||
| Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi | Q34768688 | ||
| RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription | Q34808200 | ||
| Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection | Q35082203 | ||
| Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations | Q35175284 | ||
| Entry of influenza A Virus with a α2,6-linked sialic acid binding preference requires host fibronectin | Q36276551 | ||
| 5'-Triphosphate-short interfering RNA: potent inhibition of influenza A virus infection by gene silencing and RIG-I activation. | Q36276670 | ||
| Severe influenza A(H1N1)pdm09 infection induces thymic atrophy through activating innate CD8(+)CD44(hi) T cells by upregulating IFN-γ. | Q36291097 | ||
| An overlapping protein-coding region in influenza A virus segment 3 modulates the host response | Q36554219 | ||
| The origin and global emergence of adamantane resistant A/H3N2 influenza viruses | Q37250829 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza A virus | Q834390 |
| P304 | page(s) | 23746 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome | |
| P478 | volume | 6 |
| Q30234600 | Drug resistance in influenza A virus: the epidemiology and management |
| Q40092344 | Evolution of Influenza A Virus by Mutation and Re-Assortment |
| Q92099111 | Host Cell Mimic Polymersomes for Rapid Detection of Highly Pathogenic Influenza Virus via a Viral Fusion and Cell Entry Mechanism |
| Q57063400 | Identification of two residues within the NS1 of H7N9 influenza A virus that critically affect the protein stability and function |
| Q52594783 | Molecular cloning, polymorphism, and expression analysis of the LKB1/STK11 gene and its association with non-specific digestive disorder in rabbits. |
| Q63246353 | Recent Updates on Mouse Models for Human Immunodeficiency, Influenza, and Dengue Viral Infections |
Search more.